Macrocyclic indole derivatives useful as hepatitis C virus inhibitors

Details for Australian Patent Application No. 2009281138 (hide)

Owner Tibotec Pharmaceuticals

Inventors Mc Gowan, David Craig; Vendeville, Sandrine Marie Helene; Raboisson, Pierre Jean-Marie Bernard; TahriI, Abdellah

Agent Shelston IP

Pub. Number AU-A-2009281138

PCT Pub. Number WO2010/018233

Priority 08162435.5 14.08.08 EP

Filing date 14 August 2009

Wipo publication date 18 February 2010

International Classifications

C07D 515/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/018233 Priority application(s): WO2010/018233

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281139-Transgenic plants

2009281133-Method for extracting phosphorous from solids using active leaching and phosphate-accumulating microorganisms